Try our beta test site
228 studies found for:    neurocutaneous
Show Display Options
Rank Status Study
1 Completed
Has Results
Repair of Soft Tissue Defect of the Finger Using the Heterodigital Neurocutaneous Island Flap
Conditions: Sensory Reconstruction of the Volar Aspect of the Finger;   The Heterodigital Neurocutaneous Island Flap
Intervention: Device: the neurocutaneous island flap
2 Completed Reconstruction of a Neurocutaneous Defect of the Proximal Phalanx With a Heterodigital Arterialized Nerve Pedicle Flap
Condition: Complex Digital Injuries
Intervention: Procedure: Composite Flap
3 Completed
Has Results
Repair of Infective Wound Associated With Nerve Defect in the Finger Using A Bipedicled Nerve Flap
Conditions: Infection Wound;   Disruption of Nerve Repair
Intervention: Device: Nerve flap
4 Recruiting Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers
Condition: Sjogren-Larsson Syndrome (SLS)
5 Completed Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome
Condition: Sturge- Weber Syndrome
Intervention: Drug: Drug: Topical Rapamycin
6 Completed Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I
Conditions: Neurofibromatosis Type 1;   Von Recklinghausen Disease;   NF1
7 Completed Sensory Reconstruction of the Digits
Condition: Soft Tissue Defect of Digit
Intervention: Procedure: innervated sensate flap
8 Active, not recruiting Longitudinal Study of Neurologic, Cognitive, and Radiologic Outcomes of PHACE Syndrome
Condition: PHACE Syndrome
9 Recruiting Susceptibility Genes in Autism Spectrum Disorders
Condition: Autism Spectrum Disorders
10 Recruiting A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
Condition: Von Hippel-Lindau Syndrome
Interventions: Drug: Ranibizumab;   Drug: E10030
11 Recruiting Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
Condition: Von Hippel-Lindau Disease
12 Enrolling by invitation Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?
Condition: Von Hippel-Lindaus Disease
13 Completed Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease
Condition: Von Hippel-Lindau Disease
Intervention: Drug: Sunitinib
14 Recruiting Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease
Condition: Von Hippel-Lindau Disease
15 Completed EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Hippel-Lindau Disease
Intervention: Drug: EYE001
16 Active, not recruiting Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System
Condition: Hemangioblastoma (HB) of the Central Nervous System (CNS)
Intervention: Other: evaluation of anxiety with psychosocial scales
17 Enrolling by invitation Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)
Condition: Von Hippel-Lindau Disease
Intervention: Drug: Vorinostat
18 Terminated Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
Conditions: Hemangioblastomas;   Von Hippel Lindau Disease
Intervention: Drug: Avastin
19 Completed Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Conditions: Von Hippel-Lindau Disease;   Central Nervous System Capillary Hemangioblastoma;   Retinal Capillary Hemangioblastoma
Intervention: Drug: PTK787/ZK 222584
20 Active, not recruiting Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
Conditions: Hemangioblastoma;   Hippel Lindau Disease

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.